Company / Operating Margin
Integra Lifesciences Holdings Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-30.2%
FY2025
5-year range
-30.2% / 15.3%
FY2021-FY2025
Trend
-1814.2%
vs FY2024
Sector context
#131 of 148
Health Care
What the data says
Operating Margin changed -1814% YoY in FY2025, a notable deviation from the 9-year average annual change of -206%.
Based on SEC 10-K filings.
-30.2% in FY2025 with a 5-year CAGR of -41.2%.
Declined from 7.2% to -30.2% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -45.5pp
- 5-Year Change
- -41.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 148This company -30.2% Sector average -284.8%
▼
+89.4% above sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 1814.2% year-over-year.
- Currently 254.6pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -30.2% | -1814.2% |
| FY2024 | 1.8% | -75.7% |
| FY2023 | 7.2% | -52.9% |
| FY2022 | 15.3% | +19.9% |
| FY2021 | 12.8% | +16.0% |
| FY2020 | 11.0% | +78.5% |
| FY2019 | 6.2% | -18.0% |
| FY2018 | 7.5% | -16.4% |
| FY2017 | 9.0% | +5.9% |
| FY2016 | 8.5% | -5.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026